Iofina CEO on record revenue & growth strategy for 2024

Proactive - Interviews for investors

Iofina PLC CEO Dr Tom Becker talked with Proactive about the company’s latest half-year results, ongoing iodine production, and future growth plans. In this interview, Dr. Becker highlights Iofina's record revenue, which has been driven by sustained demand for iodine, particularly in healthcare applications. Despite a slight decrease in iodine prices during the first half of 2024, the company is seeing positive market dynamics with prices recovering in the second half of the year. Becker also discusses Iofina’s growth strategy, focusing on the recent completion of its IO#10 plant and plans to commence production shortly. "Production at IO#10 will start this month," said Becker, noting that the company is also preparing to launch its next plant, IO#11, by the end of the year. The company expects strong cash flows and improved iodine production for the second half, supported by favourable weather conditions and rising iodine prices. To stay updated on Iofina’s growth and developments, check out Proactive’s YouTube channel for more interviews and insights. Don't forget to give this video a like, subscribe to the channel, and turn on notifications for future updates! #Iofina #IodineProduction #IofinaPLC #TomBecker #IO10Plant #IodinePrices #HealthcareIodine #IodineMarket #GrowthStrategy #ProactiveInvestors #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews